Now accepting early access partners

Validation that moves
at the speed of science.

EVOLV | The Validation Factory

The first AI-native Computer System Validation platform built for GAMP 5, 21 CFR Part 11, and FDA QMSR. Generate compliant URS, automate risk assessment, and govern AI model changes — in minutes, not months.

Request Early Access ▶ Try Live Demo
GAMP 5 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 2025 GMP Annex 11 EU GMP

The Problem

CSV validation still runs on
spreadsheets and email chains.

Life sciences teams spend months on documentation that should take days. Regulatory guidance has changed. Most platforms haven't.

📋

Weeks to generate a URS

Requirements written manually in Word, reviewed in meetings, rewritten after audit findings. No regulatory traceability. No version control. Just documents.

⚠️

Regulations change. VMPs don't.

FDA's QMSR replaced the QSR on February 2, 2026. The PCCP final guidance landed August 2025. Most validation plans still cite rules that no longer exist.

🤖

AI in GxP with no governance

Drug interaction predictors and defect classifiers are being deployed with no PCCP, no change control, no audit trail. FDA inspectors are starting to notice.

The Platform

One platform.
The entire validation lifecycle.

From first requirement to post-market governance — every step compliant, auditable, and powered by AI that knows GAMP 5.

📄

Validation Factory

Generate GAMP 5-compliant URS from plain English. SMART refinement, PCCP verification, UR/FR decomposition, CSA test scripts, and PDF export with e-signature — in one guided workflow. What took days takes minutes.

URS Generation SMART Refinement UR/FR Decomposition CSA Test Scripts PDF + E-Signature
🔄

Change Control

ServiceNow change requests cross-referenced against your system portfolio in real time. GxP classification, GAMP-aware risk calculation using Severity × Occurrence × Detectability, and automatic revalidation flags. No spreadsheet required.

ServiceNow Integration GxP Classification GAMP Risk Matrix Revalidation Flags
🤖

AI Model Governance

Validated AI models treated as GAMP Category 5 assets. PCCP-aware change assessment aligned to FDA final guidance August 2025. Human-in-the-loop approval queue with 21 CFR Part 11 compliant audit trail.

PCCP Assessment HITL Governance FDA Aug 2025 21 CFR Part 11
📊

Portfolio Dashboard

Every system, every site, every phase — one view. RAG status, action items, regulatory due dates. Register new systems with GxP classification and track their full validation journey from plan to monitor. Built for QA Heads and CTOs.

RAG Status System Registry Lifecycle Tracking Multi-Site

See It In Action

Watch EVOLV handle in 4 minutes
what takes your team weeks.

Three real workflows. No voiceover scripts. No slides. Just the platform doing what it's built to do.

Demo 01

Portfolio Dashboard

Your entire validated system landscape — GAMP category, GxP status, risk level, revalidation due dates — in one view. Built for QA Heads and CTOs who need portfolio-wide compliance visibility instantly..

Demo 02

Change Control & GxP Classification

ServiceNow CR received → portfolio cross-reference → GAMP risk calculation → revalidation decision. Automatic.

Demo 03

AI Model Governance

AI model change in a validated system → PCCP assessment → Governance Hub → human-in-the-loop approval → 21 CFR Part 11 audit trail. Built for FDA's final guidance (Aug 2025).

Try the Validation Factory — live, right now.

Generate a real GAMP 5-compliant URS from your own requirement. No login required.

▶ Open Live Demo

Built For

EVOLV speaks the language
of regulated industries.

Whether you're defending a validation package in an inspection or governing 150 systems across 25 sites — EVOLV gives you the records to back it up.

🧪 QA Head · CSV Manager

Stop writing in Word. Start validating.

EVOLV generates, verifies, and manages your entire validation portfolio with a complete audit trail FDA inspectors can review on the spot.

  • URS from plain English in minutes
  • SMART requirements, auto-verified against GAMP 5
  • Full lifecycle tracking — Plan to Monitor
  • Audit-ready PDFs with e-signature

📋 VP Regulatory Affairs

FDA updated the rules. EVOLV already knows.

QMSR is mandatory. PCCP guidance is final. EVOLV cites the right regulations, routes the right changes, and produces the records you need when an inspector walks in.

  • Aligned to FDA PCCP Guidance Aug 18, 2025
  • 21 CFR Part 820 QMSR / ISO 13485:2016
  • SHA-256 tamper-evident audit trail
  • 21 CFR Part 11 electronic records

💻 CTO · CDO

Your AI models are GAMP Cat 5 assets.

EVOLV gives you the governance infrastructure to deploy AI in GxP contexts without regulatory exposure — with a full HITL approval layer and immutable decision records.

  • AI model registry with version history
  • PCCP-aware change assessment
  • Human-in-the-loop governance hub
  • Portfolio-wide RAG visibility

Regulatory Coverage

GAMP 5 (2nd Edition) 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 18, 2025 GMP Annex 11 EU GMP GLP ISO 17025 GDPR 21 CFR Part 820.35 QMSR FDA CSA Guidance 2022

Early Access

Join our first cohort of life sciences partners.

We're working with a small group of pharma and biotech companies before general availability. Early access partners get priority onboarding, direct access to the founding team, and founding-tier pricing locked in permanently.

🔒  We'll respond within 1 business day. Your information is never shared.

Strategic Planning Essentials for Life Science Companies

Feb 04, 2026

Understanding the Importance of Strategic Planning

In the competitive world of life sciences, strategic planning is not just beneficial—it's essential. Life science companies face unique challenges, from regulatory hurdles to rapid technological advancements. Strategic planning helps organizations navigate these complexities by setting clear, achievable goals. This process involves assessing current capabilities, market conditions, and potential obstacles to ensure the company's long-term success.

A well-structured strategic plan acts as a roadmap, guiding companies through the intricacies of the industry. It enables organizations to allocate resources efficiently and make informed decisions that align with their overarching objectives.

strategic planning

Key Components of a Strategic Plan

Developing a strategic plan involves several critical components. These elements work together to create a comprehensive framework that supports effective decision-making:

  1. Vision and Mission: Define the core purpose and long-term aspirations of the company.
  2. SWOT Analysis: Identify strengths, weaknesses, opportunities, and threats to understand the internal and external environment.
  3. Objectives: Set specific, measurable, achievable, relevant, and time-bound (SMART) goals.
  4. Action Plans: Develop detailed strategies to achieve the objectives, including timelines and responsible parties.

Vision and Mission

The vision and mission statements are foundational components of any strategic plan. The vision articulates where the company aims to be in the future, while the mission defines its purpose and primary objectives. Together, they provide a sense of direction and inspire stakeholders.

vision mission

Conducting a SWOT Analysis

A SWOT analysis is a critical step in strategic planning for life science companies. By evaluating strengths, weaknesses, opportunities, and threats, organizations gain insights into their internal capabilities and external market conditions. This analysis helps identify areas for improvement and potential growth opportunities.

Strengths might include proprietary technology or strong partnerships, while weaknesses could be limited resources or skills gaps. Opportunities may arise from emerging markets or technological advancements, and threats could include regulatory changes or increased competition.

Setting SMART Objectives

Establishing SMART objectives is vital for turning strategic vision into reality. These objectives must be:

  • Specific: Clearly defined to avoid ambiguity.
  • Measurable: Quantifiable to track progress.
  • Achievable: Realistic given available resources.
  • Relevant: Aligned with broader goals.
  • Time-bound: Set within a clear timeline.
smart goals

Creating Action Plans

Action plans translate strategic objectives into actionable steps. These plans should outline specific tasks, assign responsibilities, and establish timelines. By detailing how goals will be achieved, action plans ensure that all team members understand their roles and contribute effectively to the company's success.

Regularly reviewing and updating action plans is crucial to accommodate changes in the industry and maintain alignment with strategic objectives. This iterative process helps life science companies remain agile and responsive to evolving market conditions.